TLR4 and acute kidney injury: In our present study, we focused on the classical inflammation pathway and we did find that Dex affected this pathway in OALT-induced AKI, which has been confirmed by using NRK-52E cell line to show dexmedetomidine directly suppress the TLR4/NF-κB pathway activation mostly via adrenoceptor alpha 2A receptor.